WO2017156967A1 - Utilisation d'étonogestrel dans la préparation de produits contre le lymphome b - Google Patents

Utilisation d'étonogestrel dans la préparation de produits contre le lymphome b Download PDF

Info

Publication number
WO2017156967A1
WO2017156967A1 PCT/CN2016/094103 CN2016094103W WO2017156967A1 WO 2017156967 A1 WO2017156967 A1 WO 2017156967A1 CN 2016094103 W CN2016094103 W CN 2016094103W WO 2017156967 A1 WO2017156967 A1 WO 2017156967A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell lymphoma
cell
etonogestrel
drug
preparation
Prior art date
Application number
PCT/CN2016/094103
Other languages
English (en)
Chinese (zh)
Inventor
师咏勇
宋智健
Original Assignee
上海交通大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海交通大学 filed Critical 上海交通大学
Publication of WO2017156967A1 publication Critical patent/WO2017156967A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'étonogestrel dans la préparation de produits contre le lymphome B.
PCT/CN2016/094103 2016-03-18 2016-08-09 Utilisation d'étonogestrel dans la préparation de produits contre le lymphome b WO2017156967A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610156842.5A CN105816467B (zh) 2016-03-18 2016-03-18 Etonogestrel在制备抗B细胞淋巴瘤产品中的应用
CN201610156842.5 2016-03-18

Publications (1)

Publication Number Publication Date
WO2017156967A1 true WO2017156967A1 (fr) 2017-09-21

Family

ID=56523843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/094103 WO2017156967A1 (fr) 2016-03-18 2016-08-09 Utilisation d'étonogestrel dans la préparation de produits contre le lymphome b

Country Status (2)

Country Link
CN (1) CN105816467B (fr)
WO (1) WO2017156967A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816467B (zh) * 2016-03-18 2019-01-22 上海交通大学 Etonogestrel在制备抗B细胞淋巴瘤产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012314A (zh) * 2015-06-30 2015-11-04 上海交通大学 Etonogestrel在制备抗前列腺癌产品中的应用
CN105816467A (zh) * 2016-03-18 2016-08-03 上海交通大学 Etonogestrel在制备抗B细胞淋巴瘤产品中的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012314A (zh) * 2015-06-30 2015-11-04 上海交通大学 Etonogestrel在制备抗前列腺癌产品中的应用
CN105816467A (zh) * 2016-03-18 2016-08-03 上海交通大学 Etonogestrel在制备抗B细胞淋巴瘤产品中的应用

Also Published As

Publication number Publication date
CN105816467A (zh) 2016-08-03
CN105816467B (zh) 2019-01-22

Similar Documents

Publication Publication Date Title
Nawroth et al. Organ‐on‐a‐chip systems for women's health applications
WO2017156967A1 (fr) Utilisation d'étonogestrel dans la préparation de produits contre le lymphome b
US20220152046A1 (en) Applications for estradiol in preparing anti-small cell lung cancer and/or ovarian cancer and/or osteosarcoma products
WO2017000083A1 (fr) Utilisation de nicardipine dans la préparation d'un produit de lutte contre le cancer du poumon
WO2017000085A1 (fr) Utilisation de sunlidac dans la préparation d'un produit de lutte contre le cancer du poumon
WO2017000078A1 (fr) Utilisation du désogestrel dans la préparation d'un produit de lutte contre le cancer colorectal/le cancer du sein négatif avec récepteurs ahr et er
WO2017000080A1 (fr) Utilisation de l'oestrone dans la préparation d'un produit de lutte contre le cancer de l'ovaire et/ou le cancer du sein
WO2017000081A1 (fr) Utilisation de l'étonorgestrel dans la préparation d'un produit permettant de lutter contre l'adénocarcinome de la prostate
WO2017000082A1 (fr) Utilisation du lévonorgestrel dans la préparation d'un produit permettant de lutter contre le cancer de l'ovaire
WO2017000084A1 (fr) Utilisation de la prométhazine pour la préparation d'un produit de lutte contre le cancer du foie et/ou le cancer colorectal et/ou le cancer du poumon
Li et al. The flavonoid baicalein negatively regulates progesterone target genes in the uterus in vivo
CN105012314B (zh) Etonogestrel在制备抗前列腺癌产品中的应用
Klabnik et al. Heat-induced increases in body temperature in lactating dairy cows: impact on the cumulus and granulosa cell transcriptome of the periovulatory follicle
CN104983733B (zh) Nicardipine在制备抗肺癌产品中的应用
US20240156834A1 (en) Applications for estradiol in preparing anti-small cell lung cancer and/or ovarian cancer and/or osteosarcoma products
CN104983734B (zh) Estradiol在制备抗小细胞肺癌和/或卵巢癌和/或骨肉瘤产品中的应用
Lew et al. Contact-free co-culture model for the study of innate immune cell activation during respiratory virus infection
CN105030785B (zh) Promethazine在制备抗肝癌和/或结肠癌和/或肺癌产品中的应用
Nikitina et al. Microbiota of the vagina and myoma nodes in uterine myoma
Tewary Does the DPP4 inhibitor sitagliptin increase the endometrial mesenchymal stem cell count in those with recurrent pregnancy loss?
Schrott A NOVEL STEM LEYDIG CELL CULTURE SYSTEM AND ITS USE IN ASSESSING THE EFFECTS OF PHTHALATE EXPOSURE ON LEYDIG CELL DEVELOPMENT

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16894128

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16894128

Country of ref document: EP

Kind code of ref document: A1